Fibre, appetite and GLP-1
GLP-1 was a niche piece of gut physiology until a drug class made it a household word. The hormone itself is older news, and your colon has been involved in it the whole time.
Where the hormone comes from
Scattered through the lining of your intestine are enteroendocrine cells — sensors that release hormones in response to what passes them. One type, the L-cell, secretes GLP-1 and a second hormone, PYY. Both act to slow gastric emptying and to signal fullness.
The detail that matters here is location. L-cells are sparse in the upper small intestine and become progressively denser further down, with the highest densities in the ileum and colon. The satiety sensor sits at the far end of the tract, not at the beginning.
Which raises an obvious question. Most of a meal is absorbed well before it gets there. So what is the far end sensing?
Two routes fibre engages
The first is physical. A viscous fibre slows gastric emptying, so nutrients arrive in the small intestine more gradually and over a longer window. Sensing is stretched out rather than concentrated into a short spike. This route is pure mechanics — it needs no bacteria and no fermentation, only viscosity.
The second is the interesting one. L-cells carry receptors called FFAR2 and FFAR3, and what these receptors bind is short-chain fatty acids. Acetate, propionate and butyrate — the products of fermentation. Engaging them triggers GLP-1 and PYY release (Tolhurst et al., 2012).
Read that alongside the anatomy and it resolves. The densest population of satiety sensors sits exactly where fermentation happens, carrying receptors for exactly what fermentation produces. Fermentation is not incidental to appetite signalling. It is one of its inputs.
What has actually been shown in people
The mechanism has been tested reasonably directly. Researchers built a molecule that carries propionate through the small intestine and releases it in the colon, so they could deliver the fermentation product to the right place without relying on which bacteria a person happened to have.
Taking it raised circulating GLP-1 and PYY and reduced how much people ate at a subsequent meal. Over twenty-four weeks it was associated with less weight gain and less increase in abdominal fat than the control (Chambers et al., Gut, 2015).
That is a real trial of a real mechanism, and it is worth knowing about. It is also a study of a purpose-built delivery molecule rather than of a fibre supplement, and the two are not interchangeable.
The scale question, stated plainly
Here is where a lot of fibre marketing quietly misleads, so it is worth being blunt.
Fibre nudges an endogenous system. Your own L-cells release your own GLP-1, in the amounts a body releases hormones, and it is cleared within minutes. A GLP-1 receptor agonist drug is engineered to resist that clearance and to occupy the receptor continuously at levels far above anything a meal produces.
These are not the same intervention at different strengths. They are different in kind. Any product implying that a fibre is a natural version of a GLP-1 drug is either confused or counting on you to be.
What is fair to say is narrower and still interesting: fermentation is one of the physiological inputs to appetite signalling, it operates through a mechanism that has been demonstrated in people, and it works at the scale that physiology works at.
Go deeper: if you are taking a GLP-1 medication
These drugs work partly by slowing gastric emptying and gut transit. That is the intended effect, not a side effect.
Two consequences follow from everything in this course. Slower transit means more contact time, so fermentable material is fermented more completely and the whole profile shifts earlier along the colon than it would otherwise. And constipation is among the more commonly reported effects of this drug class, which is a matter of record rather than an inference.
What that adds up to for any individual — including whether adding a viscous or fermentable fibre to an already-slowed gut is sensible, and in what amount — is a question for the clinician managing the medication. It is genuinely not something a general article can answer, and we are not going to pretend otherwise.
The densest population of appetite sensors in your body sits at the far end of your gut, carrying receptors for the products of fermentation. That is a real mechanism, operating at physiological scale — which is not the scale the drugs work at.
What to hold on to
Appetite is not governed only by what you absorb. Part of the signal comes from what your bacteria make out of what you could not absorb, sensed by cells positioned where that happens.
The next chapter takes up a second effect of the same gel, and this one requires no bacteria at all.
Nothing here is medical advice, and nothing here is a claim about any product. If you take medication of any kind, decisions about what to add belong with your clinician.